CME
Frontline Fixed-Duration Therapy in CLL: Improving Outcomes and Tolerability
Host: Thomas Kipps, MD, PhD Host: William Wierda, MD, PhD Determining the optimal treatment regimen for patients with chronic lymphocytic leukemia (CLL) has been a clinical challenge, especially since most patients are older than 70 years, p